Cancer Vaccine

Companies Form Partnership for Theratope Cancer Vaccine

Published in Cancer Weekly, May 19th, 1997

Chiron Corp., Emeryville, California, and Biomira Inc., Edmonton, Alberta, Canada, announced that they have formed a partnership through which the companies co-develop Biomira's Theratope immunotherapeutic vaccine.

Theratope is a synthetic cancer vaccine designed to stimulate a patient's own immune system to control the disease with minimal side effects. The partnership capitalizes on the strengths of Chiron Therapeutics in the development, registration, and marketing of biological products for oncology and on Biomira's strengths in immunology, vaccine development, and manufacturing of the Theratope vaccine.

Biomira has primary responsibility for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-05-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry